You are here

AusPAR: Rituximab

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

5 May 2021
AusPAR Details
AusPAR
Active Ingredient
Rituximab
Product Name
Ruxience
Sponsor
Pfizer Australia Pty Ltd
Submission Number
PM-2020-00593-1-6
Submission Type
New biosimilar
Decision
Approved
AusPAR Date
12 April 2021
Publication Date

5 May 2021